Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

TO ALL. I do not know what a buyout offer would gather in a Global Pandemic COVID-19 World.

However, here is what I do know.

Chris Moreau, CEO @ Algernon Pharmaceuticals. The guy who is steering the ship and dotting all the I's and crossing all the T's

Told us in prior webinars from Proactive and BioPub, that a "pure comparator" company would be BELLUS Health.

Bellus Health is a one trick pony with a leading compound for Chronic Cough.

Let me repeat that.

BELLUS Health is a one trick pony with a leading compound for Chronic Cough.

Bellus Health is currently in Phase 2 clinical trial with their Cronic Cough drug.

Algernon has reported in black and white:

Algernon Pharmaceuticals’ NP-120 (Ifenprodil) Outperforms Merck’s Phase 3 Drug MK-7264 (Gefapixant) in an Acute Cough Study by 110%

BELLUS Health has reported their Chronic Cough drug outperformed Merck by 60%

So what's better 110% or 60%.

BELLUS Health recently reported:

The Company decided to close the trial early due to the impact of the COVID-19 pandemic on the RELIEF clinical trial activities. The Company continues to expect topline data from the trial mid-year 2020.

The stock is taking a hit today for whatever whatever (could be profit taking). I'm not an investor so I don't follow the money to much.

Anyway, BELLUS Health has a market cap hovering around 500M to 600M USD.

Their a Canadian company with a good story behind it, but nothing as compelling as Algernon's story.

So that get's us to some numbers.

It's my belief the Chronic Cough angle alone is worth a Billion dollars.

There's nobody in the market with an approved Chronic Cough drug - NOBODY YET.

So what might NP-120 do for a Big Pharma company?

A treatment for Chronic Cough, Idiopathic Pulmonary Fibrosis, Acute Lung Injury, and COVID-19.

Now I don't profess to know shit from shinola, but from what I gather a Billion Dollar valuation might be a start, but could be a lowball number that piss off the bosses at Algernon.

So whatever the number is I'd imagine big pharma will come with a big number upfront.

But here's the unknowable IMO.

In a COVID-19 World, with the right data read out, Algernon could skyrocket on the news alone.

I mean we could litteraly be in clinical trial for a couple few weeks and the world will have to STOP THE PRESSES!

!!!EXTRA EXTRA - READ ALL ABOUT IT!!!

ALGERNON PHARMACEUTICALS NP-120 DEFEATS COVID-19

How do you even begin to put a value on a headline like that?

Billions is what I figure!!!

Ronald McDonald Opines:

i'm luvin it

Just 1 opinion,

/////AMG

Outro